Sensory Endovascular Robot

Informations projet

SER

N° de convention de subvention: 190123213

DOI

10.3030/190123213

Projet clôturé

Date de signature de la CE 28 Avril 2022

Date de début 1 Mai 2022

Date de fin 31 Juillet 2024

Financé au titre de

• The European Innovation Council (EIC)

Coût total

€ 3 559 093,75

Contribution de l’UE

€ 2 491 365,63

Coordonné par

UAB INOVATYVI MEDICINA
Lithuania

Periodic Reporting for period 2 - SER (Sensory Endovascular Robot)

Période du rapport: 2023-05-01 au 2024-07-31

Résumé du contexte et des objectifs généraux du projet

We have developed a smart, sensory, teleoperated robotic system for endovascular procedures – Sentante. Using a robotic system doctors may perform the full endovascular intervention from a different room, in the future – even from a different hospital. Tele-operated robotic system completely eliminates X-ray radiation for all medical personnel and provides new functionalities enabled by robotic technology – extreme precision, motion scaling, enhanced instrument control, superior X-ray visualisation, among others. Intuitive controls and universal compatibility with marketed endovascular devices make Sentante ideal for fast implementation into the routine clinical workflow with almost no additional training for doctors. Patients will benefit from better access to treatment, particularly in urgent cases with no need for patient transportation from a local hospital. Hospitals will benefit from optimized 24/7 service, the ability to retain experienced doctors, attract more patients. AI implementation and partial automatization of some of the procedures are planned for the future.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

The main technical objective of the SER project was to develop the Sentante endovascular robot system from the pre-project β prototype (TRL6) to a system ready for clinical trial (TRL7). During the project, we have successfully developed Sentante robotic system for peripheral endovascular interventions. Sentante system was optimized for different endovascular devices and peripheral procedures. Intuitively controlled using conventional endovascular instruments as the interface, the system senses operators’ movements and provides close to natural haptic force feedback – while working remotely, physicians can experience the same sensation of guidewire and catheter resistance in real time just as if they were working near the patient.
The Sentante system was successfully validated in number of pre-clinical tests (cadaver tests, animal tests, GLP animal study) as well as first in human clinical trial. The system will receive CE mark after the project and will be commercialized in the EU and the US markets.
New patent applications were submitted to protect relevant IP.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

Sentante is the first tele-operated endovascular robot in the world which is capable of performing an entire endovascular procedure, thus enabling telemedicine. Sentante has unique features that makes tele-intervention possible: it is compatible with most standard of the shelf endovascular instruments and it is capable to manipulate 3 over the wire instruments simultaneously, allowing an entire procedure – from very beginning to very end to be performed robotically.

Sentante does not change clinical workflow or instruments used in the procedure. It just enables remote work for the doctor. While working remotely, doctors work the same way they are trained to - the interface with the robot is via the same instruments as in a manual procedure and haptic force feedback allows to feel the catheter and guidewire resistance just as if they would work manually next to a patient.

Sentante robotic system transforms the way endovascular procedures are performed - it allows performance of the entire endovascular procedure remotely:
- Enabling telemedicine and 24/7 coverage;
- Improving hospital efficiency (cost optimisation, specialisation, digitisation);
- Improving the procedure (increasing accuracy and precision, reducing medical error):
- Empowering physicians - superb control of the procedure with haptic feedback and new functionalities;
- Providing an ergonomic, remote workplace without x-ray exposure to medical personnel.